Chairmans Address to Shareholders
Filed with ASX · · 20 pages · English
Please find attached addresses to shareholders to be delivered by the Chair and the Chief Executive Officer at CSL Limited’s Annual General Meeting today. Shareholder attention is drawn to a revised FY21 outlook, details of which are provided in slide 9 of the attached presentation. Net profit after tax is now expected to be approximately $2.170 to $2.265 billion at constant currency, implying a g
Earlier from CSL
- CSL Supply Agreement for UQ Vaccine with Commonwealth
- Statutory Accounts for the Full Year Ended 30 June 2020
- CSL to acquire LateStage Gene Therapy Candidate from uniQure
- Change in Leadership of CSLs Finance Function
- New Debt Facilities to Strengthen Maturity Profile
Later from CSL
- Update on UQ-CSL v451 COVID-19 Vaccine
- Dividend/Distribution - CSL
- Statutory Accounts for the Half Year Ended 31 Dec 2020
- Update on CSL Agreement with uniQure
- CSL Statutory Accounts for the Full Year Ended 30 June 2021
Follow CSL into a list and get an email when it puts out news.
Follow CSL